The podcast "The Journal" discusses the crisis at Kenvue, the maker of Tylenol, after President Trump, influenced by RFK Jr., publicly condemned Tylenol due to a purported link between acetaminophen and autism. The episode explores Kenvue CEO Kirk Perry's background, the company's efforts to address the concerns, and the potential impact on Tylenol's brand and Kenvue's overall business. It also examines the conflicting scientific data regarding the link between acetaminophen and autism, the company's response, and the broader implications for pharmaceutical companies navigating the Trump administration's health policies. The podcast draws parallels to Tylenol's handling of the cyanide poisoning crisis in the 1980s, while highlighting the unique challenges posed by the current situation.
Sign in to continue reading, translating and more.
Continue